Antibody Reagents Market - Analysis & Global Forecast to 2020
An antibody reagent is an antibody which is applied as a probe in an experimental technique to identify a specific molecular target of interest, with the goal of detection, isolation, and modulation of this target. These reagents are bioengineered through antibody production process to recognize a specific molecular antigen of interest, or a large target containing unspecified antigen.
In the report, the antibody reagents market has been studied on the basis of type, source, applications, end user, and geographies.
On the basis of type, the market is categorized into monoclonal antibody reagents and polyclonal antibody reagents. Based on the source, the market is segmented into human, mouse, and non-human primate. On the basis of applications, the market is categorized into therapeutics, diagnostics, and research. Based on the end user, the market is segmented into pharmaceutical and biotechnology companies, diagnostic laboratories, and research institutes. On the basis of geographies, the market is divided into North America, Europe, Asia, and Rest of the World.
Over the years, the demand for antibody reagents is likely to increase owing to the rise in demand for monoclonal antibodies globally, and rising R&D expenditure of pharmaceutical and biotechnology companies. Moreover, emerging markets of India and China, and increasing risk of pandemics and infectious diseases are likely to create huge opportunity for antibody reagents.
Major players in the global antibody reagents market include Abcam, PLC. (U.K.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Merck Mellipore Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Santa Cruz Biotechnology, Inc. (U.S.), Bio Legend, Inc. (U.S.), eBioscience, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cell Signaling Technology, Inc. (U.S.).
Table of Contents
1. Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.3 Key Data From Secondary Sources
2.3.1 Primary Research
2.3.2 Key Industry Insights
2.4 Key Data From Primary Sources
2.5 Key Insights From Primary Sources
2.6 Market Size Estimation Methodology
2.7 Market Forecast Methodology
2.8 Market Data Validation and Triangulation
2.9 Assumptions for the Study
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
5. Antibody Reagents Market, By Type
5.1 Introduction
5.2 Monoclonal Antibody Reagents
5.3 Polyclonal Antibody Reagents
6. Antibody Reagents Market, By Source
6.1 Introduction
6.2 Human
6.3 Mouse
6.4 Non-Human Primate
7. Antibody Reagents Market, By Application
7.1 Introduction
7.2 Therapeutics
7.3 Diagnostics
7.4 Research
8. Antibody Reagents Market, By End User
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Diagnostic Laboratories
8.4 Research Institutes
9. Antibody Reagents Market, By Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)
10. Competitive Landscape
10.1 Overview
10.2 Market Share Analysis, Antibody Reagents Market
10.3 Competitive Situation and Trends
11. Company Profiles
11.1 Introduction
11.2 ABCAM PLC
11.3 Bio-Rad Laboratories, Inc.
11.4 Beckman Coulter, Inc.
11.5 Merck Millipore Corporation
11.6 Sigma-Aldrich Corporation
11.7 Santa Cruz Biotechnology, Inc.
11.8 Biolegend, Inc.
11.9 Ebioscience., Inc.
11.10 Becton, Dickinson and Company
11.11 Cell Signaling Technology, Inc.
12. Appendix
12.1 Discussion Guide
12.2 Company Developments (2012–2015)
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
*Top 10 companies in the market will be covered
#Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
Growth opportunities and latent adjacency in Antibody Reagents Market